ALLIE KNICELY: Open Payments
NPI 1003217928 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 16 payments from 7 companies in 2025. Trend: 2023 $304 · 2024 $442 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $103 |
| Novo Nordisk Inc | 5 | $101 |
| Lilly USA, LLC | 5 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Abbott Laboratories | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| MILLICENT US INC | 1 | $17 |
Products named: Veozah, Wegovy, MOUNJARO, ZEPBOUND, Lynkuet, FREESTYLE LIBRE 3, Mirena, SPRAVATO.
Industry payments across TX — which companies pay providers there.
